Viewing Study NCT05354557


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-01-02 @ 12:58 AM
Study NCT ID: NCT05354557
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-18
First Post: 2022-04-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module